Table 1.
IBD patients | N = 49 |
---|---|
Age (mean ± SD) | 44.48 ± 14.34 |
Sex (%M) | 69% |
Treatment and duration | |
Drug free | 24.50% |
5‐ASA | 51% (12–144 months) |
Anti‐TNF | 24.5% (3–48 months) |
Activity of the disease | |
Remission | 26.5% |
Active | 73.5% |
Non‐IBD controls | N = 18 |
---|---|
Age (mean ± SD) | 47.11 ± 17.47 |
Sex (%M) | 44% |
Note. Socio demographic and clinical characteristics of individuals involved in the study.